Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition

Clinics

Volumn 67, Issue 7, 2012, Pages 761-765

  Stein, Anna ^a,b   Goldmeier, Silvia ^a   Voltolini, Sarah ^a   Setogutti, Enio ^c   Feldman, Carlos ^a,c   Figueiredo, Eduardo ^d   Eick, Renato ^a   Irigoyen, Maria ^a,f   Rigatto, Katya ^e  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Serviço de Investigação Diagnostica SIDI Ltda   (Brazil)

^d MR Res Latin America GE Healthcare   (Brazil)

^e UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BOLD; Captopril; Healthy subjects; Renal Oxygenation; Renin angiotensin system

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXYGEN;

ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; KIDNEY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; TIME; VASCULARIZATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; FEMALE; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OXYGEN; TIME FACTORS;

EID: 84867069551     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(07)10     Document Type: Article

References (40)

1. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol. 2003;14(8):2178-87, http://dx.doi.org/10.1097/01.ASN.0000079042.13465.1A.
2. Alcazar JM, Rodicio JL. Ischemic nephropathy: clinical characteristics and treatment. Am J Kidney Dis. 2000;36(5):883-93, http://dx.doi.org/10.1053/ajkd.2000.19077.
3. Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl. 2005(98):S11-7.
4. Brosius FC 3rd, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation. Hypertension. 2006;48(4):751-5.
5. Wang TM, Chang PL, Kao PF, Hsieh ML, Huang ST, Tsui KH. The role of diuretic renography in the evaluation of obstructed hydronephrosis after pediatric pyeloplasty. Chang Gung Med J. 2004;27(5):344-50.
6. Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol. 2008;19(4):780-8, http://dx.doi.org/10.1681/ASN.2007040420.
7. Brenner BM, Goldszer RC, Hostetter TH. Glomerular response to renal injury. Contrib Nephrol. 1982;33:48-66.
8. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med. 2004;43(1):9-17, http://dx.doi.org/10.2169/internalmedicine.43.9.
9. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006;17(1):17-25.
10. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int. 1991;40(4):632-42, http://dx.doi.org/10.1038/ki.1991.255.
11. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation. 1996;94(12):3271-5.
12. Nangaku M, Inagi R, Miyata T, Fujita T. Angiotensin-induced hypoxia in the kidney: functional and structural changes of the renal circulation. Adv Exp Med Biol. 2007;618:85-99, http://dx.doi.org/10.1007/978-0-387-75434-5_7.
13. Kondo N, Kiyomoto H, Yamamoto T, Miyatake A, Sun GP, Rahman M, et al. Effects of calcium channel blockade on angiotensin II-induced peritubular ischemia in rats. J Pharmacol Exp Ther. 2006;316(3):1047-52.
14. Nangaku M, Fujita T. Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertens Res. 2008;31(2):175-84, http://dx.doi.org/10.1291/hypres.31.175.
15. Prasad PV, Chen Q, Goldfarb JW, Epstein FH, Edelman RR. Breath-hold R2* mapping with a multiple gradient-recalled echo sequence: application to the evaluation of intrarenal oxygenation. J Magn Reson Imaging. 1997;7(6):1163-5, http://dx.doi.org/10.1002/jmri.1880070633.
16. Schachinger H, Dieterle T, Martina B, Haberthur C, Huber PR, Bock A, et al. Increased renovascular response to angiotensin II in persons genetically predisposed to arterial hypertension disappears after chronic angiotensin-converting enzyme inhibition. J Hypertens. 2004;22(1):175-80, http://dx.doi.org/10.1097/00004872-200401000-00027.
17. Hall JE, Granger JP. Renal hemodynamic actions of angiotensin II: interaction with tubuloglomerular feedback. Am J Physiol. 1983;245(2):R166-73.
18. Sadowski EA, Fain SB, Alford SK, Korosec FR, Fine J, Muehrer R, et al. Assessment of acute renal transplant rejection with blood oxygen leveldependent MR imaging: initial experience. Radiology. 2005;236(3):911-9, http://dx.doi.org/10.1148/radiol.2363041080.
19. Epstein FH, Prasad P. Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int. 2000;57(5):2080-3, http://dx.doi.org/10.1046/j.1523-1755.2000.00057.x.
20. Johnston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension. 1994;23(2):258-68.
21. Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37(4): 1047-52.
22. Prasad P, Li LP, Halter S, Cabray J, Ye M, Batlle D. Evaluation of Renal Hypoxia in Diabetic Mice by BOLD MRI. Investigative radiology. 2010; 45(12):819-22, http://dx.doi.org/10.1097/RLI.0b013e3181ec9b02.
23. Ries M, Basseau F, Tyndal B, Jones R, Deminiere C, Catargi B, et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging. 2003;17(1):104-13, http://dx.doi.org/10.1002/jmri.10224.
24. Mattson DL, Roman RJ, Cowley AW Jr. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension. 1992;19(6 Pt 2):766-9.
25. Imig JD. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension. Am J Hypertens. 2000;13(7):810-8, http://dx.doi.org/10.1016/S0895-7061(00)00264-8.
26. Solski LV, Longyhore DS. Prevention of type 2 diabetes mellitus with angiotensin-converting-enzyme inhibitors. Am J Health Syst Pharm. 2008;65(10):935-40, http://dx.doi.org/10.2146/ajhp070388.
27. Chen SX, Song T, Zhou SH, Liu YH, Wu SJ, Liu LY. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats. European journal of pharmacology. 2008;584(2-3):368-75, http://dx.doi.org/10.1016/j.ejphar.2008.02.020.
28. Badzynska B, Sadowski J. Opposed effects of prostaglandin E2 on perfusion of rat renal cortex and medulla: interactions with the renin-angiotensin system. Experimental physiology. 2008;93(12):1292-302, http://dx.doi.org/10.1113/expphysiol.2008.043604.
29. Kellerman PS. Cellular and metabolic consequences of chronic ischemia on kidney function. Semin Nephrol. 1996;16(1):33-42.
30. Juillard L, Lerman LO, Kruger DG, Haas JA, Rucker BC, Polzin JA, et al. Blood oxygen level-dependent measurement of acute intra-renal ischemia. Kidney Int. 2004;65(3):944-50, http://dx.doi.org/10.1111/j.1523-1755.2004.00469.x.
31. Schachinger H, Klarhofer M, Linder L, Drewe J, Scheffler K. Angiotensin II decreases the renal MRI blood oxygenation level-dependent signal. Hypertension. 2006;47(6):1062-6, http://dx.doi.org/10.1161/01.HYP.0000220109.98142.a3.
32. Simon-Zoula SC, Hofmann L, Giger A, Vogt B, Vock P, Frey FJ, et al. Non-invasive monitoring of renal oxygenation using BOLD-MRI: a reproducibility study. NMR Biomed. 2006;19(1):84-9, http://dx.doi.org/10.1002/nbm.1004.
33. Hofmann L, Simon-Zoula S, Nowak A, Giger A, Vock P, Boesch C, et al. BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int. 2006;70(1):144-50, http://dx.doi.org/10.1038/sj.ki.5000418.
34. Epstein FH, Veves A, Prasad PV. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care. 2002;25(3):575-8, http://dx.doi.org/10.2337/diacare.25.3.575.
35. Zuo CS, Rofsky NM, Mahallati H, Yu J, Zhang M, Gilbert S, et al. Visualization and quantification of renal R2* changes during water diuresis. J Magn Reson Imaging. 2003;17(6):676-82, http://dx.doi.org/10.1002/jmri.10314.
36. Blantz RC, Konnen KS, Tucker BJ. Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest. 1976;57(2):419-34, http://dx.doi.org/10.1172/JCI108293.
37. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76(2):425-536.
38. Prasad PV, Epstein FH. Changes in renal medullary pO2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: effects of aging and cyclooxygenase inhibition. Kidney Int. 1999;55(1):294-8, http://dx.doi.org/10.1046/j.1523-1755.1999.00237.x.
39. Gloviczki ML, Lerman LO, Textor SC. Blood Oxygen Level-Dependent (BOLD) MRI in Renovascular Hypertension. Current hypertension reports.13(5):370-7.
40. Chrysochou C, Mendichovszky IA, Buckley DL, Cheung CM, Jackson A, Kalra PA. BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease. Nephrol Dial Transplant. 2012;27(3):1013-9, http://dx.doi.org/10.1093/ndt/gfr392.